XML 16 R5.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Consolidated Statements of Stockholders' Equity - USD ($)
Common Stock
Additional Paid-in capital
Accumulated other comprehensive loss
Accumulated deficit
Total
Equity, beginning balance at Dec. 31, 2019 $ 21,023 $ 226,284,548 $ (11,533,778) $ (90,528,263) $ 124,243,530
Equity, beginning balance (in shares) at Dec. 31, 2019 21,022,752        
Increase (Decrease) in Stockholders' Equity          
Exercise of stock options $ 32 29,491     29,523
Exercise of stock options (in shares) 32,090        
Stockbased compensation   905,471     905,471
Foreign currency translation     (2,424,653)   (2,424,653)
Net loss       (9,400,257) (9,400,257)
Equity, ending balance at Mar. 31, 2020 $ 21,055 227,219,510 (13,958,431) (99,928,520) 113,353,614
Equity, ending balance (in shares) at Mar. 31, 2020 21,054,842        
Equity, beginning balance at Dec. 31, 2019 $ 21,023 226,284,548 (11,533,778) (90,528,263) 124,243,530
Equity, beginning balance (in shares) at Dec. 31, 2019 21,022,752        
Increase (Decrease) in Stockholders' Equity          
Foreign currency translation         (667,870)
Net loss         (25,768,184)
Equity, ending balance at Jun. 30, 2020 $ 21,187 228,597,264 (12,201,648) (116,296,447) 100,120,356
Equity, ending balance (in shares) at Jun. 30, 2020 21,186,827        
Equity, beginning balance at Mar. 31, 2020 $ 21,055 227,219,510 (13,958,431) (99,928,520) 113,353,614
Equity, beginning balance (in shares) at Mar. 31, 2020 21,054,842        
Increase (Decrease) in Stockholders' Equity          
Exercise of stock options $ 132 121,294     121,426
Exercise of stock options (in shares) 131,985        
Stockbased compensation   1,256,460     1,256,460
Foreign currency translation     1,756,783   1,756,783
Net loss       (16,367,927) (16,367,927)
Equity, ending balance at Jun. 30, 2020 $ 21,187 228,597,264 (12,201,648) (116,296,447) 100,120,356
Equity, ending balance (in shares) at Jun. 30, 2020 21,186,827        
Equity, beginning balance at Dec. 31, 2020 $ 21,187 231,418,356 (10,037,261) (144,007,075) 77,395,207
Equity, beginning balance (in shares) at Dec. 31, 2020 21,186,827        
Increase (Decrease) in Stockholders' Equity          
Stockbased compensation   1,822,562     1,822,562
Foreign currency translation     (402,850)   (402,850)
Net loss       (9,668,755) (9,668,755)
Equity, ending balance at Mar. 31, 2021 $ 21,187 233,240,918 (10,440,111) (153,675,830) 69,146,164
Equity, ending balance (in shares) at Mar. 31, 2021 21,186,827        
Equity, beginning balance at Dec. 31, 2020 $ 21,187 231,418,356 (10,037,261) (144,007,075) 77,395,207
Equity, beginning balance (in shares) at Dec. 31, 2020 21,186,827        
Increase (Decrease) in Stockholders' Equity          
Foreign currency translation         (209,830)
Net loss         (19,919,768)
Equity, ending balance at Jun. 30, 2021 $ 21,187 235,104,416 (10,247,091) (163,926,843) 60,951,669
Equity, ending balance (in shares) at Jun. 30, 2021 21,186,827        
Equity, beginning balance at Mar. 31, 2021 $ 21,187 233,240,918 (10,440,111) (153,675,830) 69,146,164
Equity, beginning balance (in shares) at Mar. 31, 2021 21,186,827        
Increase (Decrease) in Stockholders' Equity          
Stockbased compensation   1,863,498     1,863,498
Foreign currency translation     193,020   193,020
Net loss       (10,251,013) (10,251,013)
Equity, ending balance at Jun. 30, 2021 $ 21,187 $ 235,104,416 $ (10,247,091) $ (163,926,843) $ 60,951,669
Equity, ending balance (in shares) at Jun. 30, 2021 21,186,827